S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Sao Paulo Exchange · Brazil · Updated after 15 Oct 2026 close

IQVIA Holdings Inc.

I1QV34 · Sao Paulo Exchange · prices in BRL
BRL 79.70▲ +0.00 (0.00%)
Research reportHistorical data

About IQVIA Holdings Inc.

IQVIA Holdings is a healthcare information and clinical research company. It provides data, analytics and consulting services to pharmaceutical, biotechnology and medical device companies, and it runs clinical trials and other outsourced research work for those customers. Its services help clients understand markets, develop medicines and manage clinical studies. The company is based in the United States and serves healthcare and life sciences customers around the world.

IQVIA Holdings Inc. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code I1QV34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

46/ 100
Market X-Ray · price-based
Weak price profile
Ranks #909 of 1454 on the Sao Paulo Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendFair
60/100
Mixed trend against its averages.
See the numbers →
Above 200-day average15.4%
From 52-week high-75.7%
MomentumStrong
83/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return21.3%
6-month return43.3%
12-month, skipping last month23.7%
Stability (higher is calmer)Weak
5/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)281.1%
Worst drawdown, 1 year (smaller is calmer)-75.7%
LiquidityWeak
27/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.01M BRL
Zero-volume days80.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
Price trend
Above 200-day, below 50-day
Versus its 50- and 200-day averages
52-week range
49.30 – 328.55
Price is 11% of the way up
Returns
+21.3% 3m · +16.8% 1y
Price returns, dividends not included
RSI (14)
46
Neutral zone

Price chart

52-wk range 49.30 – 328.55 Daily closes, split-adjusted

Signals

50-day average91.87
200-day average69.05
Golden/death cross (60d)Golden, 41 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)4.06

Technical summary

Daily
Neutral
7 bullish · 1 neutral · 8 bearish
Weekly
Strongly bullish
9 bullish · 1 neutral · 2 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 1081.49Bearish
EMA 1081.11Bearish
SMA 2082.95Bearish
EMA 2082.90Bearish
SMA 5091.87Bearish
EMA 5083.67Bearish
SMA 10076.20Bullish
EMA 10078.86Bullish
SMA 20069.05Bullish
EMA 20073.30Bullish
Oscillators (daily)
RSI (14)46.08Neutral
MACD (12, 26)-2.22Bearish
Momentum (12)-5.57Bearish
Stochastic %K (14)0.00Bullish
Williams %R (14)-100.0Bullish
CCI (20)-114.9Bullish
Pivot points (classic, last session)
S3
79.70
S2
79.70
S1
79.70
Pivot
79.70
R1
79.70
R2
79.70
R3
79.70
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.

Prices are end-of-day closes in BRL. Educational only, not financial advice.